|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-8-9
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The combination of multiple cycles of rituximab and intravenous immune globulins has been reported to be effective in patients with severe pemphigus. The aim of this study was to assess the efficacy of a single cycle of rituximab in severe types of pemphigus.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal...,
http://linkedlifedata.com/resource/pubmed/chemical/Desmogleins,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Isotypes,
http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone,
http://linkedlifedata.com/resource/pubmed/chemical/rituximab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BedaneChristopheC,
pubmed-author:BernardPhilippeP,
pubmed-author:CauxFrédéricF,
pubmed-author:D'IncanMichelM,
pubmed-author:DelaporteEmmanuelE,
pubmed-author:DoutreMarie-SylvieMS,
pubmed-author:DrenoBrigitteB,
pubmed-author:FranckNathalieN,
pubmed-author:GilbertDanièleD,
pubmed-author:GougeonMarie-LiseML,
pubmed-author:HertlMichaelM,
pubmed-author:JacquotSergeS,
pubmed-author:JolyPascalP,
pubmed-author:MouquetHugoH,
pubmed-author:MullerRalfR,
pubmed-author:MusettePhilippeP,
pubmed-author:PauwelsChristineC,
pubmed-author:PicardCatherineC,
pubmed-author:RoujeauJean-ClaudeJC,
pubmed-author:Tancrede-BohinEmmanuelleE,
pubmed-author:TronFrançoisF
|
|
pubmed:copyrightInfo |
Copyright 2007 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
9
|
|
pubmed:volume |
357
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
545-52
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17687130-Aged,
pubmed-meshheading:17687130-Anti-Inflammatory Agents,
pubmed-meshheading:17687130-Antibodies,
pubmed-meshheading:17687130-Antibodies, Monoclonal,
pubmed-meshheading:17687130-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:17687130-B-Lymphocytes,
pubmed-meshheading:17687130-Desmogleins,
pubmed-meshheading:17687130-Drug Administration Schedule,
pubmed-meshheading:17687130-Drug Therapy, Combination,
pubmed-meshheading:17687130-Female,
pubmed-meshheading:17687130-Follow-Up Studies,
pubmed-meshheading:17687130-Humans,
pubmed-meshheading:17687130-Immunoglobulin Isotypes,
pubmed-meshheading:17687130-Immunologic Factors,
pubmed-meshheading:17687130-Infusions, Intravenous,
pubmed-meshheading:17687130-Male,
pubmed-meshheading:17687130-Middle Aged,
pubmed-meshheading:17687130-Pemphigus,
pubmed-meshheading:17687130-Prednisone,
pubmed-meshheading:17687130-Remission Induction
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A single cycle of rituximab for the treatment of severe pemphigus.
|
|
pubmed:affiliation |
Rouen University Hospital, Rouen, France. Pascal.Joly@chu-rouen.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
